Cognitive impairment in chronic obstructive pulmonary disease

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Crişan, Alexandru F ^a   Oancea, Cristian ^a   Timar, Bogdan ^a   Fira Mladinescu, Ovidiu ^a   Crişan, Alexandru ^a   Tudorache, Voicu ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; CARBON DIOXIDE TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; EDUCATION; ERYTHROCYTE SEDIMENTATION RATE; FORCED EXPIRATORY VOLUME; HUMAN; MILD COGNITIVE IMPAIRMENT; MONTREAL COGNITIVE ASSESSMENT; OBSERVATIONAL STUDY; QUESTIONNAIRE; SMOKING; VERY ELDERLY; ATTENTION; COGNITION; COMPLICATION; FEMALE; MALE; MEMORY DISORDER; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECALL;

ADULT; AGED; AGED, 80 AND OVER; ATTENTION; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; COGNITION; FEMALE; FIBRINOGEN; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MEMORY DISORDERS; MENTAL RECALL; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SURVEYS AND QUESTIONNAIRES;

EID: 84904513598     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102468     Document Type: Article

References (23)

1. Calverley PM (1996) Neuropsychological deficits in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 51: 5-6.
2. Celli BR, Barnes PJ (2007) Exacerbations of chronic obstructive pulmonary disease. Eur Respir J; 29: 1224-38. (Pubitemid 46895385)
3. Heaton RK, Grant I, McSweeny AJ, Adams K M, Petty TL (1983) Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 143: 1941-1947. (Pubitemid 13007924)
4. Antonelli-Incalzi C, Corsonello A, Pedone C, Regno F (2006) Drawing impairment predicts mortality in severe COPD. Chest 130: 1687-1694. (Pubitemid 46033420)
5. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, et al. (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56(3): 303-8. (Pubitemid 29120227)
6. Jones PW, Agusti AG (2006) Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 27: 822-832. (Pubitemid 44914209)
7. Smith T, Gildeh N, Holmes C (2007) The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry 52(5): 329-32. (Pubitemid 46743462)
8. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, et al. (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4): 695-9. (Pubitemid 41623495)
9. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256: 183-94.
10. Dong Y, Lee WY, Basri NA, Collinson SL, Merchant RA, et al. (2012) The Montreal Cognitive Assessment is superior to the Mini-Mental State Examination in detecting patients at higher risk of dementia. Int Psychogeriatr 24(11): 1749-55.
11. Villeneuve S, Pepin V, Rahayel S, Bertrand J-A, de Lorimier M, et al. (2012) Mild Cognitive Impairment in Moderate to severe COPD, a preliminary study. Chest 142(6): 1516-1522.
12. Isoaho R, Puolijoki H, Huhti E, Laippala P, Kivela SL (1996) Chronic obstructive pulmonary disease and cognitive impairment in the elderly. Int Psychogeriatr 8: 113-125. (Pubitemid 26248777)
13. Areza-Fegyveres R, Kairalla RA, Carvalho CRR, Nitrini R (2010) Cognition and chronic Hypoxia in pulmonary disease. Dement Neuro 4(1): 14-22.
14. Grant I, Heaton RK, McSweeny AJ, Kenneth MA, Timms RM (1982) Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 142: 1470-1476. (Pubitemid 12048347)
15. Antonelli Incalzi R, Chiappini F, Fuso L, Torrice MP, Gemma A, Pistelli R (1998) Predicting cognitive decline in patients with hypoxaemic COPD. Respir Med 92(3): 527-533. (Pubitemid 28162166)
16. Solfrizzi V, D'Introno A, Colacicco AM, Capurso C, Todarello O, et al. (2006) Circulating biomarkers of cognitive decline and dementia. Clin Chim Acta 364: 91-112. (Pubitemid 43120631)
17. Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Rumley A, et al. (2007) Cognitive Decline and Markers of Inflammation and Hemostasis: The Edinburgh Artery StudyJ Am Geriatr Soc 55(5): 700-707. (Pubitemid 46668976)
18. Schram MT, Euser SM, de Craen AJ, Witteman JC, Frolich M, et al. (2007) Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc 55(5): 708-16. (Pubitemid 46668977)
19. Teuissen CE, van Boxtel MPJ, Bosma H, Bosmans E, Delanghe J, et al. (2003) Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol 134(1-2): 142-50. (Pubitemid 36054172)
20. Whitney NP, Eidem TM, Pen H, Huang Y, Zheng JC (2009) Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders. J Neurochem 108(6): 1343-59.
21. Di Carlo A, Lamassa M, Baldereschi M, Inzitari M, Scafato E, et al. (2007) CIND and MCI in the Italian elderly: frequency, vascular risk factor, progression to dementia. Neurology 68: 1909-16. (Pubitemid 46848623)
22. Butterfield DA, Sultana R (2007) Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder. J Alzheimers Dis 12(1): 61-72. (Pubitemid 47396301)
23. Sabia S, Elbaz A, Dugravot A, Head J, Shipley M, et al. (2012) Impact of smoking on cognitive decline in early old age: the Whitehall II cohort study, Arch Gen Psychiatry 69(6): 627-635.